Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Narasimha M Beeraka, Runze Zhou, Xiaoyan Wang, Hemanth Vikram P R, Tegginamath Pramod Kumar, Junqi Liu, M V Greeshma, Subhankar P Mandal, B M Gurupadayya & Ruitai Fan. (2022) Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR). International Journal of Nanomedicine 17, pages 2121-2138.
Read now
Read now
Arja Viinanen, Mariann I Lassenius, Iiro Toppila, Antti Karlsson, Lauri Veijalainen, Juhana J Idänpään-Heikkilä & Tarja Laitinen. (2019) The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2409-2421.
Read now
Read now
Victoria S Benson, Katie C Pascoe, James Siddall, Mark Small & Hana Müllerová. (2019) Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2711-2723.
Read now
Read now
Nicola A Hanania, Sanjay Sethi, Arkady Koltun, Jonathan K Ward, Jacqui Spanton & Dik Ng. (2019) Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 117-127.
Read now
Read now
James F Donohue, Donald A Mahler & Sanjay Sethi. (2019) Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2947-2958.
Read now
Read now
Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, Alexia Richard, Weihua Cao, Bettina Hederer, Jutta Beier, Oliver Kornmann & Richard N van Zyl-Smit. (2018) Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3923-3936.
Read now
Read now
Donald P Tashkin. (2016) A review of nebulized drug delivery in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2585-2596.
Read now
Read now
Articles from other publishers (13)
You Xu, Hongmei Liu & Lei Song. (2020) Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review. Journal of Nanobiotechnology 18:1.
Crossref
Crossref
Roxana Cortes-Lopez & Igor Barjaktarevic. (2020) Alpha-1 Antitrypsin Deficiency: a Rare Disease?. Current Allergy and Asthma Reports 20:9.
Crossref
Crossref
Meenu Mehta, Daljeet S. Dhanjal, Keshav R. Paudel, Bhupender Singh, Gaurav Gupta, S. Rajeshkumar, Lakshmi Thangavelu, Murtaza M. Tambuwala, Hamid A. Bakshi, Dinesh K. Chellappan, Parijat Pandey, Harish Dureja, Nitin B. Charbe, Sachin K. Singh, Shakti D. Shukla, Srinivas Nammi, Alaa A. Aljabali, Peter R. Wich, Philip M. Hansbro, Saurabh Satija & Kamal Dua. (2020) Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update. Inflammopharmacology 28:4, pages 795-817.
Crossref
Crossref
Katharinne Ingrid Moraes Carvalho, Diego de Sá Coutinho, Humberto Cavalcante Joca, Artur Santos Miranda, Jader dos Santos Cruz, Emerson Teixeira Silva, Marcus Vinícius Nora Souza, Robson Xavier Faria, Patricia Machado Rodrigues e Silva, Jorge Carlos Santos Costa & Marco Aurélio Martins. (2020) Anti-Bronchospasmodic Effect of JME-173, a Novel Mexiletine Analog Endowed With Highly Attenuated Anesthetic Activity. Frontiers in Pharmacology 11.
Crossref
Crossref
Aernout Haarst, Lorcan McGarvey & Sabina Paglialunga. (2019)
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease:
US
and
EU
Perspectives
. Clinical Pharmacology & Therapeutics 106:6, pages 1222-1235.
Crossref
Crossref
Krishna K. Pudi, Chris N. Barnes, Edmund J. Moran, Brett Haumann & Edward Kerwin. (2017) A 28-day, randomized, double-blind, placebo-controlled, parallel group study of nebulized revefenacin in patients with chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser, James Krainson, Luis Delacruz, Samir Arora, Gregory Feldman, Krishna Pudi, Shahid Siddiqui, Chad Orevillo, Andrea Maes, Earl St. Rose & Ubaldo Martin. (2017) 24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD. Respiratory Research 18:1.
Crossref
Crossref
Michael Schivo, Timothy E Albertson, Angela Haczku, Nicholas J Kenyon, Amir A Zeki, Brooks T Kuhn, Samuel Louie & Mark V Avdalovic. (2023) Paradigms in Chronic Obstructive Pulmonary Disease: Phenotypes, Immunobiology, and Therapy with a Focus on Vascular Disease. Journal of Investigative Medicine 65:6, pages 953-963.
Crossref
Crossref
Meenakshi Patel, Karl Steinberg, Manuel Suarez-Barcelo, Dana Saffel, Rick Foley & Chad Worz. (2017) Chronic Obstructive Pulmonary Disease in Post-acute/Long-term Care Settings: Seizing Opportunities to Individualize Treatment and Device Selection. Journal of the American Medical Directors Association 18:6, pages 553.e17-553.e22.
Crossref
Crossref
J. Sadlonova, D. Osinova, E. Rozborilova, O. Osina, E. Novakova & V. Sadlonova. 2017. Clinical Management of Pulmonary Disorders and Diseases. Clinical Management of Pulmonary Disorders and Diseases
45
52
.
Poonsit Hiransai, Jitbanjong Tangpong, Chuthamat Kumbuar, Namon Hoonheang, Onrunee Rodpech, Padchara Sangsuk, Urairat Kajklangdon & Waraphorn Inkaow. (2016) Anti-nitric oxide production, anti-proliferation and antioxidant effects of the aqueous extract from Tithonia diversifolia. Asian Pacific Journal of Tropical Biomedicine 6:11, pages 950-956.
Crossref
Crossref
Zhichao Pan, Haishan Yu & Jie-Lou Liao. (2016) Probing Cellular and Molecular Mechanisms of Cigarette Smoke-Induced Immune Response in the Progression of Chronic Obstructive Pulmonary Disease Using Multiscale Network Modeling. PLOS ONE 11:9, pages e0163192.
Crossref
Crossref
Christopher B Cooper & Igor Barjaktarevic. (2015) COPD management: need for more consensus – Authors' reply. The Lancet Respiratory Medicine 3:7, pages e22-e23.
Crossref
Crossref